Glecaprevir/pibrentasvir for 8 Weeks in Treatment-Naïve Patients with Chronic HCV Genotypes 1-6 and Compensated Cirrhosis: the EXPEDITION-8 Trial.
Journal of hepatology(2020)
Key words
Chronic HCV infection,Compensated cirrhosis,Direct-acting antiviral,Glecaprevir/pibrentasvir,HCV elimination,Hepatitis C virus,Pangenotypic,Short duration
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined